TerraSky Co.,Ltd. (TYO:3915)
Japan · Delayed Price · Currency is JPY 2,349.00
-2.00 (-0.09%)
Aug 1, 2025, 3:30 PM JST
Orchard Therapeutics Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2017 - 2021 |
| 25,505 | 24,709 | 19,137 | 15,440 | 12,578 | 11,144 | Upgrade | |
Revenue Growth (YoY) | 23.85% | 29.12% | 23.94% | 22.75% | 12.87% | 19.83% | Upgrade |
Cost of Revenue | 18,674 | 18,035 | 14,125 | 11,179 | 8,973 | 7,852 | Upgrade |
Gross Profit | 6,831 | 6,674 | 5,012 | 4,261 | 3,605 | 3,292 | Upgrade |
Selling, General & Admin | 5,360 | 5,222 | 4,489 | 3,749 | 2,946 | 2,513 | Upgrade |
Operating Expenses | 5,360 | 5,222 | 4,489 | 3,749 | 2,946 | 2,513 | Upgrade |
Operating Income | 1,471 | 1,452 | 523 | 512 | 659 | 779 | Upgrade |
Interest Expense | -0.97 | -1 | - | -1 | -2 | -2 | Upgrade |
Interest & Investment Income | 26 | 26 | 11 | 7 | 9 | 4 | Upgrade |
Earnings From Equity Investments | 53.38 | 55 | 73 | 20 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 4.75 | 6 | 2 | -3 | -3 | -1 | Upgrade |
Other Non Operating Income (Expenses) | 85.49 | 65 | 44 | 74 | -3 | -2 | Upgrade |
EBT Excluding Unusual Items | 1,640 | 1,603 | 653 | 609 | 660 | 778 | Upgrade |
Gain (Loss) on Sale of Investments | 79.55 | 29 | - | 95 | - | 2,806 | Upgrade |
Asset Writedown | - | - | -21 | - | - | -3 | Upgrade |
Pretax Income | 1,719 | 1,632 | 632 | 704 | 660 | 3,581 | Upgrade |
Income Tax Expense | 544.65 | 461 | 232 | 260 | 312 | 1,054 | Upgrade |
Earnings From Continuing Operations | 1,175 | 1,171 | 400 | 444 | 348 | 2,527 | Upgrade |
Minority Interest in Earnings | -119.74 | -153 | -100 | -97 | -42 | -68 | Upgrade |
Net Income | 1,055 | 1,018 | 300 | 347 | 306 | 2,459 | Upgrade |
Net Income to Common | 1,055 | 1,018 | 300 | 347 | 306 | 2,459 | Upgrade |
Net Income Growth | 139.18% | 239.33% | -13.54% | 13.40% | -87.56% | 179.43% | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Change (YoY) | -0.07% | 0.02% | 0.21% | 0.07% | 0.04% | 0.48% | Upgrade |
EPS (Basic) | 81.75 | 78.91 | 23.34 | 27.12 | 23.99 | 193.97 | Upgrade |
EPS (Diluted) | 81.75 | 78.89 | 23.25 | 26.97 | 23.83 | 191.17 | Upgrade |
EPS Growth | 139.59% | 239.31% | -13.79% | 13.18% | -87.53% | 177.86% | Upgrade |
Free Cash Flow | - | 1,390 | 611 | 936 | -489 | 144 | Upgrade |
Free Cash Flow Per Share | - | 107.68 | 47.34 | 72.67 | -37.99 | 11.19 | Upgrade |
Gross Margin | - | 27.01% | 26.19% | 27.60% | 28.66% | 29.54% | Upgrade |
Operating Margin | 5.77% | 5.88% | 2.73% | 3.32% | 5.24% | 6.99% | Upgrade |
Profit Margin | 4.14% | 4.12% | 1.57% | 2.25% | 2.43% | 22.07% | Upgrade |
Free Cash Flow Margin | - | 5.63% | 3.19% | 6.06% | -3.89% | 1.29% | Upgrade |
EBITDA | 1,998 | 1,959 | 948 | 917 | 1,066 | 1,208 | Upgrade |
EBITDA Margin | - | 7.93% | 4.95% | 5.94% | 8.48% | 10.84% | Upgrade |
D&A For EBITDA | 527.5 | 507 | 425 | 405 | 407 | 429 | Upgrade |
EBIT | 1,471 | 1,452 | 523 | 512 | 659 | 779 | Upgrade |
EBIT Margin | - | 5.88% | 2.73% | 3.32% | 5.24% | 6.99% | Upgrade |
Effective Tax Rate | - | 28.25% | 36.71% | 36.93% | 47.27% | 29.43% | Upgrade |
Advertising Expenses | - | 232 | 303 | 368 | - | - | Upgrade |
Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.